Advantages of using Genetically Elevated Lipoprotein(a) Levels in Predicting 5-Year Major Adverse Cardiovascular Events Relating to Coronary Artery Disease in Women.
Aleksandr B ShekRano B AlievaAlisher A AbdullaevKhurshid G FozilovShavkat U KhoshimovGuzal J AbdullaevaDarya V ZakirovaRano A KurbanovaLilya E KanAndrey R KimPublished in: Reviews in cardiovascular medicine (2024)
gene using qPCR more accurately reflects the risk of major adverse cardiovascular events within 5 years in women with coronary artery disease.
Keyphrases
- cardiovascular events
- coronary artery disease
- percutaneous coronary intervention
- coronary artery bypass grafting
- cardiovascular disease
- polycystic ovary syndrome
- copy number
- genome wide
- adverse drug
- aortic stenosis
- emergency department
- genome wide identification
- dna methylation
- metabolic syndrome
- atrial fibrillation
- skeletal muscle
- left ventricular
- aortic valve